Clinical trial Recruiting at 1 site Interventional Ages 60 and up

Assessing the impact of geriatric evaluations on diabetes treatment for older adults

Official title: The Impact of Geriatric Assessment on the Treatment Plan of Elderly Patients With Type 2 Diabetes Mellitus: a Randomized Clinical Trial.

Run by Hospital de Clinicas de Porto Alegre · NCT06469437 · Data updated 2026-11-12

This study tests if using special evaluations for older adults can help doctors create better diabetes treatment plans for elderly patients with type 2 diabetes.

More Frailty trials

Quick facts

Study typeInterventional
Ages60 Years and up
SexAll
Enrollment220 (estimated)
SponsorHospital de Clinicas de Porto Alegre
Academic / other
Locations1 site (Porto Alegre, Rio Grande do Sul)
StatusRecruiting
StartedJuly 5, 2024
Main results expectedJune 1, 2026
Study endsDecember 31, 2028
Registry record updatedMay 29, 2026
Trial IDNCT06469437 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 60 years or older diagnosed with type 2 diabetes and currently under follow-up in a specialized endocrinology outpatient clinic.

Probably not a fit

Patients who are classified as Clinical Frailty Scale 9 or those who do not consent to participate will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates how geriatric assessments influence treatment plans for elderly patients with type 2 diabetes mellitus (T2DM). It involves a randomized controlled design with 220 participants who will be assessed using the Clinical Frailty Scale and the 10-minute Targeted Geriatric Assessment. Based on their frailty status, patients will receive tailored glycemic targets to optimize their diabetes management. The control group will receive standard treatment without the additional geriatric assessment input.

Why it matters

Potential benefit: If successful, this approach could lead to more personalized and effective diabetes management for elderly patients, improving their overall health outcomes.

How similar studies have gone: Other studies have indicated that individualized treatment approaches based on frailty assessments can improve outcomes, suggesting this method may be effective.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 60 years or older
* Diagnostic of type 2 diabetes mellitus according to American Diabetes Association criteria
* Patients under follow-up in a specialized endocrinology outpatient clinic
* Patients who have a glycated hemoglobin measurement of up to three months

Exclusion Criteria:

* Lack of consent for research participation from the patient or the physician
* Patients classified as Clinical Frailty Scale 9.

Where it's running

  • Hospital de Clínicas de Porto Alegre
    Porto Alegre, Rio Grande do Sul, Brazil
    Recruiting

Study contacts

  • Principal investigator: Renato GB Mello, Professor — Federal University of Rio Grande do Sul
  • Study coordinator: Gabriela P Rezende, Physician
  • Email: gabrielapetitot@gmail.com
  • Phone: 5551989504774

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.